bioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Up 43.1% in February

bioMérieux S.A. (OTCMKTS:BMXMF) was the recipient of a large increase in short interest in February. As of February 28th, there was short interest totalling 154,600 shares, an increase of 43.1% from the February 13th total of 108,000 shares. Approximately 0.1% of the company’s shares are short sold. Based on an average daily trading volume, of 1,300 shares, the days-to-cover ratio is presently 118.9 days.

bioMérieux Stock Performance

OTCMKTS:BMXMF opened at $123.74 on Friday. The stock’s fifty day moving average price is $117.41 and its two-hundred day moving average price is $113.33. bioMérieux has a 52-week low of $93.50 and a 52-week high of $126.64. The company has a quick ratio of 1.20, a current ratio of 2.21 and a debt-to-equity ratio of 0.10.

About bioMérieux

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.